Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 109
interventional 70
Observational 34
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 18
Drug|placebo 15
Device 7
Procedure 6
Drug|Other 3
Other 3
Biological 2
Biological|placebo 2
Device|placebo 2
Device|Procedure 2
Drug|Procedure 2
Behavioral 1
Behavioral|Device 1
Behavioral|Other 1
Combination Product 1
Combination Product|placebo 1
Device|Drug 1
Device|Other 1
Diagnostic Test 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 40
NA 5
United States|Canada 5
Canada 4
Taiwan 3
Egypt 2
Korea, Republic of 2
Belgium|Czechia|Denmark|Germany|Latvia|Lithuania|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain 1
Belgium|Czechia|Germany|Hungary|Latvia|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
Brazil|China 1
China 1
Czechia|Germany|Hungary|Poland|United Kingdom 1
Israel 1
Italy 1
Switzerland 1
United States|Canada|Denmark|Finland|France|Germany 1

Sites per Study

Site_count Study_Count
1 42
2 5
3 2
4 1
5 4
6 1
9 1
10 1
11 1
13 1
19 1
20 1
24 1
28 2
29 2
34 1
41 1
44 1
60 1

Phase

Phase Study_Count
N/A 23
Phase 2 23
Phase 4 8
Phase 3 5
Phase 1 4
Phase 1/Phase 2 4
Early Phase 1 2
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 16
2 40
3 4
4 4
5 1
NA 5

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 2.0 1.000 10 15.00 8.000 53 3.0 15.000
1st Qu. 11.5 19.500 16 27.75 59.500 53 42.0 23.750
Median 21.0 32.000 23 32.50 90.000 53 43.0 26.500
Mean 21.0 184.913 21 54.75 111.087 53 87.8 73.625
3rd Qu. 30.5 61.000 28 59.50 129.500 53 80.0 75.750
Max. 40.0 2500.000 28 139.00 400.000 53 271.0 255.000

Trial Group Type

group_type Group_Count
Experimental 49
Active Comparator 37
Placebo Comparator 31
Other 7
NA 5
Sham Comparator 3
No Intervention 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 44
Single Group Assignment 18
Crossover Assignment 4
Factorial Assignment 2
Sequential Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 63
Diagnostic 3
Other 1
Prevention 1
Screening 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 25
Korea, Republic of 4
NA 2
Switzerland 2
Portugal|United Kingdom 1

Sites per Study

Site_count Study_Count
1 29
2 2
6 2
8 1

Enrollment Metrics

Measure Observational
Min 11.0000
1st Qu 34.0000
Median 160.0000
Mean 327.7879
3rd Qu 400.0000
Max 2923.0000

Observation Model

observational_model Study_Count
Cohort 13
Case Control 9
Case-Only 3
Family-Based 3
NA 3
Case-Control 2
Other 1

Time Perspective

time_perspective Study_Count
Prospective 24
Retrospective 4
Cross-Sectional 3
NA 2
Other 1

Registries

Studies by Country

Country Study_Count
Korea, Republic of 3
Italy 1
United States 1

Sites per Study

Site_count Study_Count
1 2
2 2
4 1

Enrollment Metrics

Measure Registries
Min 40.0
1st Qu 50.0
Median 57.0
Mean 58.8
3rd Qu 67.0
Max 80.0

Registry Model

observational_model Study_Count
Cohort 3
Case-Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 3
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
1 Month 1
1 Year 1
14 Years 1
3 Months 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03282318 A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis https://ClinicalTrials.gov/show/NCT03282318 Completed Astellas Pharma Inc 2019-03-21
NCT03143920 Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder https://ClinicalTrials.gov/show/NCT03143920 Recruiting University of California, San Diego 2021-06-01
NCT03103594 Comparison of the Treatment of Refractory Bladder Pain Syndrome With DMSO and DMSO With Botulinum Toxin A https://ClinicalTrials.gov/show/NCT03103594 Completed University of Pennsylvania 2016-08-31
NCT03023241 Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis https://ClinicalTrials.gov/show/NCT03023241 Recruiting Cantonal Hospital, Frauenfeld 2019-12-31
NCT03008382 Interstitial Cystitis: Examination of the Central Autonomic Network https://ClinicalTrials.gov/show/NCT03008382 Recruiting Medical College of Wisconsin 2020-07-31
NCT02870738 Bladder Directed vs. Pelvic Floor Therapy in IC/BPS https://ClinicalTrials.gov/show/NCT02870738 Recruiting William Beaumont Hospitals 2020-08-31
NCT02856022 A Comparison of Electrical Ilioinguinal Nerve Stimulation With Intravesical Irrigation for Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT02856022 Completed Shanghai Institute of Acupuncture, Moxibustion and Meridian 2016-12-31
NCT02747420 PTNS Versus Sham Efficacy in Treatment of BPS https://ClinicalTrials.gov/show/NCT02747420 Recruiting NYU Langone Health 2020-03-31
NCT02743962 A Pilot Study Investigating the Use of a Therapeutic Wand in Addition to Physiotherapy for Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT02743962 Completed University of Bradford 2016-10-31
NCT02600715 Reduction of Bladder Injection Pain With Belladonna Opiate Suppository https://ClinicalTrials.gov/show/NCT02600715 Completed University of Kansas Medical Center 2017-06-26
NCT02547298 Interstitial Cystitis (IC)-Like Findings With Hydrodistension https://ClinicalTrials.gov/show/NCT02547298 Active, not recruiting St. Louis University 2020-08-31
NCT02497976 Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis https://ClinicalTrials.gov/show/NCT02497976 Completed ICStudy, LLC 2017-04-16
NCT02457182 Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT02457182 Completed University of New Mexico 2015-06-30
NCT02411110 A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT02411110 Completed Allergan 2016-10-12
NCT02395042 A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner’s Lesions https://ClinicalTrials.gov/show/NCT02395042 Completed Allergan 2017-06-29
NCT02297100 Intravesicular Onabotulinumtoxin A in Interstitial Cystitis https://ClinicalTrials.gov/show/NCT02297100 Completed Wake Forest University Health Sciences 2018-01-10
NCT02247557 Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis https://ClinicalTrials.gov/show/NCT02247557 Completed Buddhist Tzu Chi General Hospital 2017-02-28
NCT02232282 Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02232282 Completed Loyola University 2017-08-16
NCT02214550 Chronic Pain Risk Associated With Menstrual Period Pain https://ClinicalTrials.gov/show/NCT02214550 Recruiting NorthShore University HealthSystem 2020-09-30
NCT01294878 Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT01294878 Completed IRCCS Policlinico S. Matteo 2010-09-30
NCT02000401 Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain https://ClinicalTrials.gov/show/NCT02000401 Completed Citrus Valley Medical Research, Inc. 2013-07-31
NCT01997983 Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients https://ClinicalTrials.gov/show/NCT01997983 Completed UroGen Pharma Ltd. 2014-04-30
NCT01990898 Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action https://ClinicalTrials.gov/show/NCT01990898 Completed The Cleveland Clinic 2015-10-31
NCT01969773 Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment https://ClinicalTrials.gov/show/NCT01969773 Completed Buddhist Tzu Chi General Hospital 2014-12-31
NCT01882543 Efficacy and Safety of AQX-1125 in IC/BPS https://ClinicalTrials.gov/show/NCT01882543 Completed Aquinox Pharmaceuticals (Canada) Inc. 2015-06-30
NCT01879683 A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner’s Lesions https://ClinicalTrials.gov/show/NCT01879683 Completed Allergan 2014-05-31
NCT01613586 A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) https://ClinicalTrials.gov/show/NCT01613586 Completed Astellas Pharma Inc 2014-03-18
NCT01569438 The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Subjects With Interstitial Cystitis /Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT01569438 Completed Afferent Pharmaceuticals, Inc. 2014-05-01
NCT01559961 Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT01559961 Completed Trillium Therapeutics Inc. 2013-02-28
NCT01479725 Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis https://ClinicalTrials.gov/show/NCT01479725 Completed William Beaumont Hospitals 2012-08-31
NCT01393223 Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome https://ClinicalTrials.gov/show/NCT01393223 Completed Lipella Pharmaceuticals, Inc. 2018-06-14
NCT04208087 PK and Safety of SI-722 in IC/BPS https://ClinicalTrials.gov/show/NCT04208087 Recruiting Seikagaku Corporation 2021-02-28
NCT04118946 Platelet Enriched Plasma for Treatment of Interstitial Cystitis https://ClinicalTrials.gov/show/NCT04118946 Recruiting Mansoura University 2020-06-30
NCT04010513 Hypnosis for Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT04010513 Recruiting University of Pennsylvania 2020-09-15
NCT03987594 Comparing the Effect of Fulguration Versus Fulguration and Hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT03987594 Completed Yonsei University 2018-10-31
NCT03931538 Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study https://ClinicalTrials.gov/show/NCT03931538 Active, not recruiting Pathnostics 2019-02-22
NCT03844581 Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystitis https://ClinicalTrials.gov/show/NCT03844581 Completed Cairo University 2019-01-01
NCT03844412 Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments https://ClinicalTrials.gov/show/NCT03844412 Recruiting Duke University 2022-10-01
NCT03755375 The Effects of Physiotherapeutic Interventions Applied to the Chronic Pelvic Pain Syndrome https://ClinicalTrials.gov/show/NCT03755375 Recruiting University of Sao Paulo General Hospital 2019-09-03
NCT03722992 The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients https://ClinicalTrials.gov/show/NCT03722992 Active, not recruiting TriHealth Inc. 2020-06-30
NCT03693001 HBOT for Patients With IC/FM (Interstitial Cystitis/Fibromyalgia) https://ClinicalTrials.gov/show/NCT03693001 Completed University of South Florida 2018-06-01
NCT03619486 Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) https://ClinicalTrials.gov/show/NCT03619486 Active, not recruiting Chang Gung Memorial Hospital 2020-02-26
NCT03463915 Clinical Trial Comparing Two Bladder Instillations for IC/BPS https://ClinicalTrials.gov/show/NCT03463915 Recruiting University of Louisville 2020-12-31
NCT03463499 The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients https://ClinicalTrials.gov/show/NCT03463499 Recruiting Samsung Medical Center 2021-09-30
NCT01197261 OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) https://ClinicalTrials.gov/show/NCT01197261 Completed Mundipharma Research GmbH & Co KG 2013-03-31
NCT01195116 Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis https://ClinicalTrials.gov/show/NCT01195116 Completed University of Rochester 2012-04-30
NCT01150565 Safety Study of LiRIS in Interstitial Cystitis (IC) Patients https://ClinicalTrials.gov/show/NCT01150565 Completed Allergan 2011-09-30
NCT01083979 Intravesical Liposomes for Ulcerative Cystitis https://ClinicalTrials.gov/show/NCT01083979 Completed William Beaumont Hospitals 2010-10-31
NCT01030640 Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected https://ClinicalTrials.gov/show/NCT01030640 Completed Pfizer 2010-09-30
NCT00919802 Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00919802 Completed University of Alabama at Birmingham 2015-09-30
NCT00919113 Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome https://ClinicalTrials.gov/show/NCT00919113 Completed Watson Pharmaceuticals 2010-12-31
NCT01731470 Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) https://ClinicalTrials.gov/show/NCT01731470 Completed William Beaumont Hospitals 2013-08-31
NCT02550561 Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS https://ClinicalTrials.gov/show/NCT02550561 Completed University of California, Irvine 2017-12-31
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis https://ClinicalTrials.gov/show/NCT01295814 Completed ICStudy, LLC 2013-06-30
NCT00739739 An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00739739 Completed Pfizer 2010-01-31
NCT00733603 Physical Therapy in Women With Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00733603 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-12-31
NCT00601484 An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00601484 Completed Pfizer 2009-04-30
NCT00590473 Sacral Neuromodulation in Patients With IC https://ClinicalTrials.gov/show/NCT00590473 Completed Drexel University 2009-02-28
NCT00554320 Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain https://ClinicalTrials.gov/show/NCT00554320 Completed Summa Health System 2009-06-30
NCT00527917 A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome. https://ClinicalTrials.gov/show/NCT00527917 Completed Watson Pharmaceuticals 2008-06-30
NCT00517868 Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00517868 Completed Urigen 2008-04-30
NCT00434343 Physical Therapy Trial for Pelvic Pain https://ClinicalTrials.gov/show/NCT00434343 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2007-11-30
NCT00420550 Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC https://ClinicalTrials.gov/show/NCT00420550 Completed William Beaumont Hospitals 2007-10-31
NCT00295854 Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00295854 Completed MediciNova 2006-10-31
NCT00256542 Study of U101 for Bladder Pain and/or Urgency https://ClinicalTrials.gov/show/NCT00256542 Completed Urigen NA
NCT00194610 Botox as a Treatment for Interstitial Cystitis in Women https://ClinicalTrials.gov/show/NCT00194610 Completed University of Washington 2009-06-30
NCT00150488 URACYST® For the Treatment of GAG Deficient Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00150488 Completed Queen’s University 2008-01-31
NCT00124306 Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS) https://ClinicalTrials.gov/show/NCT00124306 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2008-04-30
NCT00056251 Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00056251 Completed ICOS Corporation NA
NCT00004316 Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis https://ClinicalTrials.gov/show/NCT00004316 Completed Office of Rare Diseases (ORD) 2007-08-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03103477 Platelet Activating Factor Stability in Urine https://ClinicalTrials.gov/show/NCT03103477 Completed St. Louis University 2017-02-28
NCT03041194 Dietary Impact on Urinary pH in Women With Interstitial Cystitis https://ClinicalTrials.gov/show/NCT03041194 Completed St. Louis University 2015-12-31
NCT03024619 Interstitial Cystitis and Urinary pH https://ClinicalTrials.gov/show/NCT03024619 Completed St. Louis University 2019-06-04
NCT02898220 Trans-MAPP II Study of Urologic Chronic Pelvin Pain https://ClinicalTrials.gov/show/NCT02898220 Recruiting University of Pennsylvania 2020-07-31
NCT02514265 Trans-MAPP Symptom Patterns Study (SPS) https://ClinicalTrials.gov/show/NCT02514265 Active, not recruiting University of Pennsylvania 2019-03-31
NCT01963988 Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients https://ClinicalTrials.gov/show/NCT01963988 Completed Samsung Medical Center 2017-10-31
NCT01895153 Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT01895153 Recruiting Samsung Medical Center 2020-05-31
NCT01738464 Microbiomes of Pelvic Pain https://ClinicalTrials.gov/show/NCT01738464 Recruiting Northwestern University 2021-03-07
NCT01616992 Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic Characteristics (ICEPAC) Study https://ClinicalTrials.gov/show/NCT01616992 Completed Case Western Reserve University 2014-12-31
NCT01482676 The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction https://ClinicalTrials.gov/show/NCT01482676 Completed University Hospital Inselspital, Berne 2012-12-31
NCT04001244 Translational Research in Pelvic Pain https://ClinicalTrials.gov/show/NCT04001244 Recruiting University of Oxford 2020-05-31
NCT03523559 Genetic and Histopathologic Characteristics of Interstitial Cystitis https://ClinicalTrials.gov/show/NCT03523559 Recruiting Samsung Medical Center 2020-03-31
NCT03468530 Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients https://ClinicalTrials.gov/show/NCT03468530 Recruiting Samsung Medical Center 2022-12-31
NCT01138800 Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis https://ClinicalTrials.gov/show/NCT01138800 Completed William Beaumont Hospitals 2012-03-31
NCT01098279 Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis https://ClinicalTrials.gov/show/NCT01098279 Completed University of Pennsylvania 2013-06-30
NCT00971568 Urinary Biomarkers Characteristic to Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00971568 Completed William Beaumont Hospitals 2011-09-30
NCT00903643 Sensory Processing in Subjects With Painful Bladder Syndrome https://ClinicalTrials.gov/show/NCT00903643 Completed University of Alabama at Birmingham 2014-06-30
NCT00903435 Quantitative Studies of Urinary Bladder Sensation https://ClinicalTrials.gov/show/NCT00903435 Completed University of Alabama at Birmingham 2009-11-30
NCT00873171 Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00873171 Completed CAMC Health System 2009-11-30
NCT03480477 Adverse Childhood Experiences in Urogynecologic Patients https://ClinicalTrials.gov/show/NCT03480477 Completed University of New Mexico 2019-02-01
NCT00810329 Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome https://ClinicalTrials.gov/show/NCT00810329 Completed Georgetown University 2011-04-30
NCT00775281 Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. https://ClinicalTrials.gov/show/NCT00775281 Completed University Hospital Inselspital, Berne 2010-04-30
NCT00751010 Relationship: Interstitial Cystitis & Vulvodynia-Part 2 https://ClinicalTrials.gov/show/NCT00751010 Completed William Beaumont Hospitals 2008-09-30
NCT00704457 Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC) https://ClinicalTrials.gov/show/NCT00704457 Completed William Beaumont Hospitals 2006-12-31
NCT00675298 Linkage Analysis in Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00675298 Completed Beth Israel Deaconess Medical Center 2011-06-30
NCT00672087 Diagnostic Challenges in IC (and Male CPPS) https://ClinicalTrials.gov/show/NCT00672087 Completed Beth Israel Deaconess Medical Center 2011-06-30
NCT00546858 Relationship of Interstitial Cystitis to Vulvodynia https://ClinicalTrials.gov/show/NCT00546858 Completed William Beaumont Hospitals 2009-05-31
NCT00499317 Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) https://ClinicalTrials.gov/show/NCT00499317 Recruiting Boston Children’s Hospital 2025-12-31
NCT00389142 Genetic Studies in Interstitial Cystitis (IC) https://ClinicalTrials.gov/show/NCT00389142 Recruiting Boston Children’s Hospital 2025-12-31
NCT00379002 The Women’s Urology Center/WISH Database Project https://ClinicalTrials.gov/show/NCT00379002 Completed William Beaumont Hospitals 2015-01-31
NCT00376298 Urology Database to Evaluate Clinical Information and Improve Patient Care. https://ClinicalTrials.gov/show/NCT00376298 Completed William Beaumont Hospitals 2015-12-31
NCT00248664 Events Preceding Interstitial Cystitis (EPIC) https://ClinicalTrials.gov/show/NCT00248664 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00237081 Genetics of Interstitial Cystitis https://ClinicalTrials.gov/show/NCT00237081 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00817388 Correlating Ic/Pbs Symptoms With Urine Biomarkers https://ClinicalTrials.gov/show/NCT00817388 Completed William Beaumont Hospitals 2010-05-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03069053 Clinical Features and Histologic Findings in Bladder Pain Syndrome/Interstitial Cystitis https://ClinicalTrials.gov/show/NCT03069053 Completed IRCCS Policlinico S. Matteo 2016-12-15
NCT03003845 S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain https://ClinicalTrials.gov/show/NCT03003845 Active, not recruiting St. Louis University 2020-07-31
NCT02331472 The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study) https://ClinicalTrials.gov/show/NCT02331472 Completed Asan Medical Center 2016-01-14
NCT02150811 Observational Study of Hunner’s Ulcer in Patient With Interstitial Cystitis/Bladder Pain Syndrome https://ClinicalTrials.gov/show/NCT02150811 Completed Asan Medical Center 2017-01-31
NCT01985880 The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome https://ClinicalTrials.gov/show/NCT01985880 Completed Asan Medical Center 2016-05-12